안녕하세요? 퀀텀바이오솔루션즈입니다.
SLP 소프트웨어와 관련하여 새롭게 업데이트된 논문을 소개드립니다.
Improving Individualized Salbutamol Treatment: A Population Pharmacokinetic Model for Oral Salbutamol in Virtual Patients.
Marques L, Vale N. (2025) Pharmaceutics. 17(1):39
Keywords: gastroplus, pbpk modeling, physiologically based pharmacokinetics, mechanistic absorption, population simulations, intersubject variability, covariates, acat
Formulation development and evaluation, in silico PBPK modeling and in vivo pharmacodynamic studies of clozapine matrix type transdermal patches.
Qadir A, Jan SU, Shoaib MH, Sikandar M, Yousuf RI, Ali FR, Siddiqui F, Magsi AJ, Mustafa G, Saleem MT, Mohammad S, Younis M, Arsalan M. (2025) Sci Rep. Jan 7;15(1):1204
Keywords: gastroplus, pbpk modeling, physiologically based pharmacokinetics, tcat, dermal absorption, transdermal formulation, skin penetration, ivpt
Dosage Optimization Using Physiologically Based Pharmacokinetic Modeling for Pediatric Patients with Renal Impairment: A Case Study of Meropenem.
Rahim N, Sarfraz M, Bello A, Naqvi SBS. (2025) AAPS PharmSciTech. Jan 16;26(1):38
Keywords: gastroplus, pbpk modeling, physiologically based pharmacokinetics, pediatrics, special populations, disease states, kidney disease, renal impairment, dose selection
In vivo performance of amorphous solid dispersions based on water-insoluble versus water-soluble carriers: Fenofibrate case study.
Schver GCRM, Novakovic J, Lee PI. (2025) Int J Pharm. Jan 18:125227
Keywords: gastroplus, pbpk modeling, physiologically based pharmacokinetics, mechanistic absorption, enabled formulations, supersaturation, precipitation kinetics, ASD
안녕하세요? 퀀텀바이오솔루션즈입니다.
SLP 소프트웨어와 관련하여 새롭게 업데이트된 논문을 소개드립니다.
Improving Individualized Salbutamol Treatment: A Population Pharmacokinetic Model for Oral Salbutamol in Virtual Patients.
Marques L, Vale N. (2025) Pharmaceutics. 17(1):39
Keywords: gastroplus, pbpk modeling, physiologically based pharmacokinetics, mechanistic absorption, population simulations, intersubject variability, covariates, acat
Formulation development and evaluation, in silico PBPK modeling and in vivo pharmacodynamic studies of clozapine matrix type transdermal patches.
Qadir A, Jan SU, Shoaib MH, Sikandar M, Yousuf RI, Ali FR, Siddiqui F, Magsi AJ, Mustafa G, Saleem MT, Mohammad S, Younis M, Arsalan M. (2025) Sci Rep. Jan 7;15(1):1204
Keywords: gastroplus, pbpk modeling, physiologically based pharmacokinetics, tcat, dermal absorption, transdermal formulation, skin penetration, ivpt
Dosage Optimization Using Physiologically Based Pharmacokinetic Modeling for Pediatric Patients with Renal Impairment: A Case Study of Meropenem.
Rahim N, Sarfraz M, Bello A, Naqvi SBS. (2025) AAPS PharmSciTech. Jan 16;26(1):38
Keywords: gastroplus, pbpk modeling, physiologically based pharmacokinetics, pediatrics, special populations, disease states, kidney disease, renal impairment, dose selection
In vivo performance of amorphous solid dispersions based on water-insoluble versus water-soluble carriers: Fenofibrate case study.
Schver GCRM, Novakovic J, Lee PI. (2025) Int J Pharm. Jan 18:125227
Keywords: gastroplus, pbpk modeling, physiologically based pharmacokinetics, mechanistic absorption, enabled formulations, supersaturation, precipitation kinetics, ASD